PREVENT study: SEC provided clinically meaningful improvement in back pain, morning stiffness, fatigue, & physical function in TNFi-naïve nr-axSpA pts over 52 weeks. #ABS1340 #ACR20 @RheumNow https://t.co/RugzhqbY2A https://t.co/5kaZWoYk9t
Links:
Secukinumab Improves Pain, Morning Stiffness, Fatigue and Physical Function in …
http://ow.ly/skdM50CenyM
08-11-2020
